Psychiatry and Neurology, Neurology · Peoria, IL
NPI
1477903219
Since 2016
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
200 E Pennsylvania Ave
Peoria, IL, 61603
Phone (309) 624-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
3,663 services
Medicare patients, 2024
267
Average age 74
Drug cost, 2024
$1.1M
2,495 prescriptions
Company payments, 2025
$91.85
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joshua S Chisholm was code J0585 (injection, onabotulinumtoxina, 1 unit), 2,575 times for 11 patients. In total Joshua S Chisholm billed 3,663 services in 21 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 2,575 | 11 | $4.94 | $13K |
| 99215 Office E&M - Established | Facility | 192 | 146 | $108.53 | $21K |
| 99215 Office E&M - Established | Office | 124 | 112 | $94.33 | $12K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 66 | 40 | $24.15 | $1,594 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 45 | 26 | $19.82 | $892 |
| 99214 Office E&M - Established | Facility | 43 | 41 | $69.68 | $2,996 |
| 99214 Office E&M - Established | Office | 33 | 32 | $62.05 | $2,048 |
| 99213 Office E&M - Established | Facility | 26 | 25 | $48.90 | $1,272 |
| 99213 Office E&M - Established | Office | 19 | 19 | $48.35 | $919 |
| 95874 Musculoskeletal | Facility | 18 | 11 | $13.72 | $247 |
| 99205 Office E&M - New | Facility | 12 | 12 | $128.88 | $1,547 |
By year: 2022 $135K for 12,159 services; 2023 $124K for 10,772 services; 2024 $70K for 3,663 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joshua S Chisholm prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 637 prescriptions and refills. In total Joshua S Chisholm wrote 2,495 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 637 | 1,633 | 171 | $22K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 196 | 517 | 55 | $7,448 |
| Propranolol Hcl Generic | 195 | 483 | 58 | $4,983 |
| Clonazepam Generic | 191 | 226 | 33 | $1,292 |
| Primidone Generic | 183 | 401 | 45 | $3,854 |
| Donepezil Hcl Generic | 174 | 464 | 51 | $2,842 |
| Rytary Carbidopa/Levodopa | 54 | 74 | Under 11 | $75K |
| Rasagiline Mesylate Generic | 51 | 117 | 14 | $8,889 |
| Amantadine Amantadine Hcl | 50 | 100 | Under 11 | $2,240 |
| Trazodone Hcl Generic | 49 | 125 | 18 | $401 |
| Quetiapine Fumarate Generic | 49 | 137 | 18 | $1,964 |
| Levetiracetam Generic | 47 | 83 | Under 11 | $962 |
| Entacapone Generic | 45 | 95 | 12 | $8,845 |
| Diazepam Generic | 41 | 41 | Under 11 | $162 |
| Tetrabenazine Generic | 40 | 40 | Under 11 | $221K |
Brand drugs: 155 claims; generic drugs: 2,340 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joshua S Chisholm $91.85 ($91.85 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $78.09.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $78.09 |
| Chiesi USA, Inc. | 1 | $13.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.